Hetixim 200 Tablet DT contains Cefixime 200 mg, a third-generation cephalosporin antibiotic effective against a broad spectrum of gram-positive and gram-negative bacteria. It is indicated for the treatment of various bacterial infections including respiratory tract infections such as bronchitis and pneumonia, urinary tract infections, otitis media, pharyngitis, tonsillitis, and uncomplicated gonorrhea. Cefixime acts by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. The tablet is designed as a dispersible form, facilitating ease of administration and improved patient compliance, particularly in pediatric and geriatric populations. Hetixim 200 Tablet DT is absorbed orally with good bioavailability and achieves therapeutic concentrations in blood and tissues. It is generally well tolerated; common adverse effects may include gastrointestinal disturbances such as diarrhea, nausea, and abdominal discomfort. Hypersensitivity reactions are rare but may occur in patients with a history of penicillin or cephalosporin allergy. Dosage should be adjusted based on the severity of infection, renal function, and patient age. Hetixim 200 Tablet DT should be used under medical supervision, with adherence to prescribed duration to prevent resistance development. It is contraindicated in patients with known hypersensitivity to cefixime or other cephalosporins.